Vijayawada: The one-man judicial commission set up by the state govt to look into the circumstances leading to the Jan 8 ...

Dr K. Vijaya Kumar Reddy, the rector, asked departments to incorporate outcome-based learning and integrate innovation without overpromising. Registrar Dr K. Venkateswara Rao added that reforms ...

RDY reports encouraging first-quarter fiscal 2026 results, wherein both earnings and revenues beat estimates, driven by higher global generic sales.

Revenue grew 11.4% to Rs 8,572 crore, but the bottom line of Rs 1,418 crore missed Bloomberg’s consensus estimate of Rs 1,514 ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Wednesday reported profit of $165 million in its fiscal first quarter. On a per-share basis, the Hyderabad, India ...

Q1FY26 revenues at ?12.7 billion, YoY growth of 142% and flat QoQ growth. This includes revenues from the acquired NRT business.

Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Dr. Reddy’s Laboratories ( NYSE: RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo ...

Dr Reddy's Laboratories posted a 1% rise in net profit to Rs 1,410 crore for the June quarter, with revenue climbing to Rs 8,545 crore. Growth stemmed from branded markets and the Nicotine Replacement ...

Dr Reddy's Laboratories reported a 1% rise in net profit for the June quarter, with revenues increasing from Rs 7,673 crore to Rs 8,545 crore. Despite facing pricing pressures in the US generic market ...